Handa Pharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

Handa Pharma General Information

Description

Operator of a pharmaceutical company intended to produce and commercialize quality prescription medications. The company uses technical expertise in the production of prescription medications in two complementary areas such as proprietary therapeutics that address significant unmet patient needs and high-barrier-to-entry generic drugs, enabling patients to access controlled-release prescription pharmaceutical products.

Contact Information

Website
www.handapharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2025 Gateway Place
  • Suite 480
  • San Jose, CA 95110
  • United States
+1 (510)
Primary Industry
Pharmaceuticals
Parent Company
Handa Pharma (Taiwan)
Vertical(s)
Life Sciences
Corporate Office
  • 2025 Gateway Place
  • Suite 480
  • San Jose, CA 95110
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Handa Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Apr-2023 Completed Generating Revenue
3. Later Stage VC 15-Jul-2019 Completed Generating Revenue
2. Merger/Acquisition 01-Feb-2016 $2.04M Completed Generating Revenue
1. Early Stage VC 31-Mar-2009 $2.04M $2.04M Completed Startup
To view Handa Pharma’s complete valuation and funding history, request access »

Handa Pharma Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Handa Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230190762-A1 Stable varenicline dosage forms Pending 25-Jun-2021
US-20210046077-A1 Kinase inhibitor salts and compositions thereof Active 15-Jun-2018
US-10098898-B1 Release stable mesalamine dosage forms Active 04-Dec-2017
AU-2016209466-A1 Stable solid fingolimod dosage forms Inactive 20-Jan-2015
EP-3247341-A4 Stable solid fingolimod dosage forms Inactive 20-Jan-2015 A61K31/137
To view Handa Pharma’s complete patent history, request access »

Handa Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fosun Pharma Corporation Minority
Taiwania Capital Venture Capital Minority
To view Handa Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Handa Pharma FAQs

  • When was Handa Pharma founded?

    Handa Pharma was founded in 2005.

  • Where is Handa Pharma headquartered?

    Handa Pharma is headquartered in San Jose, CA.

  • What industry is Handa Pharma in?

    Handa Pharma’s primary industry is Pharmaceuticals.

  • Is Handa Pharma a private or public company?

    Handa Pharma is a Private company.

  • What is Handa Pharma’s current revenue?

    The current revenue for Handa Pharma is .

  • How much funding has Handa Pharma raised over time?

    Handa Pharma has raised $2.04M.

  • Who are Handa Pharma’s investors?

    Fosun Pharma and Taiwania Capital have invested in Handa Pharma.

  • When was Handa Pharma acquired?

    Handa Pharma was acquired on 01-Apr-2023.

  • Who acquired Handa Pharma?

    Handa Pharma was acquired by Handa Pharma (Taiwan).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »